These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 3490535)

  • 21. Antiviral effect of lymphokine-activated killer cells: characterization of effector cells mediating prophylaxis.
    Bukowski JF; Yang H; Welsh RM
    J Virol; 1988 Oct; 62(10):3642-8. PubMed ID: 2458485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell activity in lymphocytic choriomeningitis virus-infected beta 2-microglobulin-deficient mice.
    Zajac AJ; Muller D; Pederson K; Frelinger JA; Quinn DG
    Int Immunol; 1995 Oct; 7(10):1545-56. PubMed ID: 8562499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotactic effect of human recombinant interleukin 2 on mouse activated large granular lymphocytes.
    Natuk RJ; Welsh RM
    J Immunol; 1987 Oct; 139(8):2737-43. PubMed ID: 3498769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function.
    Welsh RM; Brubaker JO; Vargas-Cortes M; O'Donnell CL
    J Exp Med; 1991 May; 173(5):1053-63. PubMed ID: 1850779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains.
    Ahmed R; Byrne JA; Oldstone MB
    J Virol; 1984 Jul; 51(1):34-41. PubMed ID: 6610062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.
    Borrow P; Tishon A; Oldstone MB
    J Exp Med; 1991 Jul; 174(1):203-12. PubMed ID: 1905339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    Matloubian M; Concepcion RJ; Ahmed R
    J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
    Ahmed R; Salmi A; Butler LD; Chiller JM; Oldstone MB
    J Exp Med; 1984 Aug; 160(2):521-40. PubMed ID: 6332167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus.
    Moskophidis D; Battegay M; van den Broek M; Laine E; Hoffmann-Rohrer U; Zinkernagel RM
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():381-91. PubMed ID: 7531218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.
    Hobbs JA; Cho S; Roberts TJ; Sriram V; Zhang J; Xu M; Brutkiewicz RR
    J Virol; 2001 Nov; 75(22):10746-54. PubMed ID: 11602716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.
    Bründler MA; Aichele P; Bachmann M; Kitamura D; Rajewsky K; Zinkernagel RM
    Eur J Immunol; 1996 Sep; 26(9):2257-62. PubMed ID: 8814275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
    J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
    Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
    J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.